Undisclosed BBB Repair Program
Neurodegenerative Disease (e.g., Alzheimer's Disease)
PreclinicalActive
Key Facts
Indication
Neurodegenerative Disease (e.g., Alzheimer's Disease)
Phase
Preclinical
Status
Active
Company
About Reservoir Neuroscience
Reservoir Neuroscience is an early-stage biotech targeting a novel mechanism in neurodegenerative diseases: blood-brain barrier (BBB) dysfunction. The company's core hypothesis is that repairing the BBB, a key regulator of brain homeostasis often compromised by neuroinflammation, could halt or reverse disease progression. Operating from the biotech hub of Cambridge, MA, the company is likely in a preclinical or discovery-stage phase, building its platform and pipeline. Its success hinges on validating this pioneering approach and translating it into effective clinical candidates for conditions like Alzheimer's and Parkinson's disease.
View full company profile